How do we ensure a safe ABO recheck process?
Transfusion · 2023
DOI: 10.1111/trf.17530 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, 2023. Verfasst von Laura D Stephens und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of California San Diego Health, La Jolla, California, USA. Hauptthemen laut MEDLINE: Medical Errors, Blood Transfusion. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Collecting a patient's blood in a correctly labeled pretransfusion specimen tube is essential for accurate ABO typing and safe transfusion. Noncompliance with specimen collection procedures can lead to wrong blood in tube (WBIT) incidents with potentially fatal consequences. Recent WBIT events inspired the investigation of how various institutions currently reduce the risk of these errors and ensure accurate ABO typing of patient samples. Materials and Methods This article describes the techniques employed at various institutions across the United States to mitigate the risk of misidentified pretransfusion patient specimens. Details and considerations for each of these measures are provided.
Results
Several institutions require the order for an ABO confirmation specimen, if indicated, to be generated from the transfusion medicine (TM) laboratory. Others issue a dedicated collection tube that is available exclusively from the TM service. Many institutions employ barcoding for electronic positive patient identification. Some use a combination of these strategies, depending on the locations or service lines from which the specimens are collected.
Conclusion
The description of various WBIT mitigation strategies will inform TM services on practices that may be effective at their respective institutions. Irrespective of the method(s) utilized, institutions should continue to monitor and mitigate specimen misidentification errors to promote sustained safe transfusion practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of California San Diego Health, La Jolla, California, USA.
- Johns Hopkins University School of Medicine Baltimore, Baltimore, Maryland, USA.
- University of Illinois at Chicago, Chicago, Illinois, USA.
- Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: Laura D Stephens, Evan M Bloch, Elizabeth P Crowe, Sally A Campbell-Lee, Garrett S Booth
Zitieren
APA
Stephens, L. D., Allen, E. S., Bloch, E. M., Crowe, E. P., Campbell-Lee, S. A., Booth, G. S., & Kopko, P. (2023). How do we ensure a safe ABO recheck process?. Transfusion. https://doi.org/10.1111/trf.17530
Vancouver
Stephens LD, Allen ES, Bloch EM, Crowe EP, Campbell-Lee SA, Booth GS, et al. How do we ensure a safe ABO recheck process?. Transfusion. 2023. doi:10.1111/trf.17530
BibTeX
@article{Stephens2023,
author = {Stephens, Laura D and Allen, Elizabeth S and Bloch, Evan M and Crowe, Elizabeth P and Campbell-Lee, Sally A and Booth, Garrett S and Kopko, Patricia},
title = {How do we ensure a safe ABO recheck process?},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17530}
}
EUVIMED